Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,839.98
(
0.78%
)
News Focus
News Focus

Replies to post #244344 on Biotech Values

Replies to #244344 on Biotech Values
icon url

DewDiligence

10/28/22 12:03 PM

#244345 RE: Biowatch #244344

Only in the short-run. Within a few quarters, RVNC's Daxxify sales will swamp its dermal-filler sales. Daxxify will also have a much higher profit margin than RVNC's dermal fillers.